Pharmaceutical News

RSS

Vitro toxicity testing an alternative to predict adverse health effects of drugs

In vitro toxicity testing is rapidly being adopted in the pharmaceutical, chemical, and cosmetics industries, for example, as an alternative to animal studies to predict adverse health effects of drugs and personal care products and the health consequences of environmental exposures.

8 Aug 2014

Dimethyl fumarate offers no added benefits for adults with RRMS

Dimethyl fumarate has been approved since January 2014 for adults with relapsing remitting multiple sclerosis.

8 Aug 2014

Secret of aging skin may lie in glycan and micronutrient creams

For decades, dermatologists have been researching the genetic cause of aging skin so that the perfect antidote could be developed. When examining genes and proteins, a difference between younger and older looking skin has not been found.

7 Aug 2014

New lifesaving product aims at reducing death toll from heroin abuse

A new, lifesaving product aimed at reducing the death toll from heroin abuse — developed by a professor at the University of Kentucky College of Pharmacy — is in its final round of clinical trials and has received Fast Track designation by the Food and Drug Administration.

7 Aug 2014

New tool promises to reduce deaths caused by heroin overdose

A new, lifesaving product aimed at reducing the death toll from heroin abuse - developed by a professor at the University of Kentucky College of Pharmacy - is in its final round of clinical trials and has received Fast Track designation by the Food and Drug Administration.

7 Aug 2014

New analysis outlines risks and benefits of taking aspirin to reduce risk of cancer

A new analysis published today outlines the risks and benefits of taking aspirin to reduce the risk of cancer.

7 Aug 2014

Soligenix demonstrates improved immunogenicity and rapid action of anthrax vaccine, VeloThrax

Soligenix, Inc., a clinical stage biopharmaceutical company focused on developing products to treat serious inflammatory diseases where there remains an unmet medical need, as well as developing several biodefense vaccines and therapeutics, announced today results demonstrating the improved immunogenicity and rapid action of its anthrax vaccine, VeloThrax™.

7 Aug 2014

Researchers plan to develop vaccine into a type of antibody serum therapy

By many estimates, an Ebola vaccine could be available in humans as early as next year. But will it be the right one? There are a number of vaccines in development and each is in a race to prove that it is most effective, safe and that it will protect the largest number of people.

7 Aug 2014

New study casts doubt on the effectiveness of brief counseling for illicit drug use

In an effort to stem substance use, the U.S. has invested heavily in the past decade in a brief screening-and-intervention protocol for alcohol and other drugs.

7 Aug 2014

Prompt administration of alteplase treatment reduces disability in stroke patients

Many more stroke patients could benefit from thrombolytic treatment (the use of drugs to break up or dissolve blood clots), but it needs to be administered as quickly as possible after the first signs of illness, according to new findings from the largest meta-analysis to date investigating the clot-busting drug alteplase.

7 Aug 2014

CTI BioPharma's pacritinib granted FDA Fast Track designation for treatment of myelofibrosis

CTI BioPharma Corp. announced today that pacritinib has been granted Fast Track designation by the U.S. Food and Drug Administration for the treatment of intermediate and high risk myelofibrosis, including but not limited to patients with disease related thrombocytopenia, patients experiencing treatment emergent thrombocytopenia on other JAK2 therapy or patients who are intolerant to or whose symptoms are sub-optimally managed on other JAK2 therapy.

7 Aug 2014

Immunosuppressive drugs increase risk of myeloid disorders among IBD patients

Immunosuppressive drugs called thiopurines have been found to increase the risk of myeloid disorders, such as acute myeloid leukemia and myelodysplastic syndrome, a rare bone marrow disorder, seven-fold among inflammatory bowel disease (IBD) patients.

7 Aug 2014

Study provides care coaches with useful ideas to help older patients improve asthma medication rituals

Storing it in the bathroom and making it part of a daily routine may be helpful advice that doctors can give their older asthmatic patients who struggle to remember to take their daily prescribed medication.

6 Aug 2014

Researchers identify genetic variants associated with severe skin reactions to antiepileptic drug

Researchers have identified genetic variants that are associated with severe adverse skin reactions to the antiepileptic drug phenytoin, according to a study in the August 6 issue of JAMA.

6 Aug 2014

Blood cancer patients in the UK can now benefit from Roche's MabThera SC

Patients with one of the most common forms of blood cancer can now benefit from a new injection. MabThera subcutaneous (SC), which is given to patients just beneath the skin, can be administered in approximately five minutes, compared to the current two and a half hour intravenous (IV) infusion.

6 Aug 2014

Commonly used lipid-lowering drug protects against cerebral ischemia/reperfusion injury

In addition to its lipid-lowering effect, statins exert anti-inflammatory and antioxidant effects as well.

6 Aug 2014

Roundtable discussion on heroin and prescription drug abuse

Jersey Shore University Medical Center hosted a roundtable discussion on August 4, led by Assemblywoman Mary Pat Angelini, to discuss the continued growth in heroin and prescription drug abuse in the shore community.

5 Aug 2014

Aeterna Zentaris signs strategic co-promotion services agreement with ASCEND

Aeterna Zentaris Inc. today announced a strategic co-promotion services agreement with ASCEND Therapeutics US, LLC.

5 Aug 2014

FDA grants orphan-drug designation to Genoa's pirfenidone for treatment of IPF disease

Genoa Pharmaceuticals, the leader in inhaled medicines for pulmonary fibrosis, today announced the U.S. Food and Drug Administration (FDA) has granted orphan-drug designation to Genoa for the use of pirfenidone in their lead program - inhaled GP-101 for the treatment of IPF.

5 Aug 2014

Repurposed drug used to treat ovarian cancer gives positive results

A repurposed drug originally used to treat ovarian cancer saw positive results for patients with advanced peritoneal cancers during a phase I clinical trial at The University of Kansas Cancer Center.

5 Aug 2014

Pharmaceutical News

Vitro toxicity testing an alternative to predict adverse health effects of drugs

Dimethyl fumarate offers no added benefits for adults with RRMS

Secret of aging skin may lie in glycan and micronutrient creams

New lifesaving product aims at reducing death toll from heroin abuse

New tool promises to reduce deaths caused by heroin overdose

New analysis outlines risks and benefits of taking aspirin to reduce risk of cancer

Soligenix demonstrates improved immunogenicity and rapid action of anthrax vaccine, VeloThrax

Researchers plan to develop vaccine into a type of antibody serum therapy

New study casts doubt on the effectiveness of brief counseling for illicit drug use

Prompt administration of alteplase treatment reduces disability in stroke patients

CTI BioPharma's pacritinib granted FDA Fast Track designation for treatment of myelofibrosis

Immunosuppressive drugs increase risk of myeloid disorders among IBD patients

Study provides care coaches with useful ideas to help older patients improve asthma medication rituals

Researchers identify genetic variants associated with severe skin reactions to antiepileptic drug

Blood cancer patients in the UK can now benefit from Roche's MabThera SC

Commonly used lipid-lowering drug protects against cerebral ischemia/reperfusion injury

Roundtable discussion on heroin and prescription drug abuse

Aeterna Zentaris signs strategic co-promotion services agreement with ASCEND

FDA grants orphan-drug designation to Genoa's pirfenidone for treatment of IPF disease

Repurposed drug used to treat ovarian cancer gives positive results

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Latest News